Streetbeat News

Price Targets

AMGN

Over the past 3 months, 8 analysts have published their opinion on Amgen (NASDAQ:AMGN) stock. The company has an average price target of $252.0 with a high of $310.00 and a low of $200.00. The average price target has increased by 3.99% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 8:00 pm

DPZ

In the last quarter, Domino's Pizza (NYSE:DPZ) has received various analyst ratings, with the majority being somewhat bullish or indifferent. Over the past 3 months, 36 analysts have offered 12-month price targets for Domino's Pizza, with an average price target of $391.58, a high of $483.00, and a low of $300.00. This average price target has increased by 7.93% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 8:00 pm

ASO

Telsey Advisory Group analyst Cristina Fernández initiated coverage on Academy Sports and Outdoors Inc (NASDAQ:ASO) with an Outperform rating and a price target of $72. The rating is based on a P/E multiple of ~9.0x applied to the projected 2024 EPS estimate of $8.00. The analyst views ASO as a growth story driven by market share gains as the company expands in existing and new markets. The stock's low valuation reflects the negative comp trend that began in 1Q22, expected to persist until 4Q23. However, the analyst expects a return to growth and stable profitability in 2024.

Portfolio Pulse from Shivani Kumaresan

August 14, 2023 | 7:32 pm

JAZZ

Cantor Fitzgerald analyst Charles C. Duncan has reiterated an Overweight rating on Jazz Pharmaceuticals Plc (NASDAQ:JAZZ), but lowered the price target from $210 to $180 due to a new valuation methodology and a higher cost of capital assumption. Duncan also lowered the FY23 and FY24 EPS estimates significantly. However, he praised Jazz's Q2 2023 total revenues of $957.3 million, which exceeded estimates, and the company's progress in its commercial portfolio. The analyst also highlighted the potential of Jazz's Xywav and Epidiolex drugs.

Portfolio Pulse from Nabaparna Bhattacharya

August 14, 2023 | 7:25 pm

BWXT

Truist Securities analyst Michael Ciarmoli has reiterated a Buy rating on BWX Technologies, Inc. (BWXT), raising the price target to $83 from $77. Ciarmoli believes that BWXT's numerous revenue growth drivers, monopolistic market positions, and a resurgence in the commercial nuclear market will enable it to post best-in-class results among its peers over the next 12-36 months. The analyst also sees signs of microreactor adoption in the commercial market and anticipates that the high-margin medical rev growth acceleration will complement stability in the company's core naval defense market.

Portfolio Pulse from Nabaparna Bhattacharya

August 14, 2023 | 7:22 pm

DBRG

Over the past 3 months, 6 analysts have published their opinion on DigitalBridge Gr (NYSE:DBRG) stock. The company has an average price target of $18.83, with a high of $25.00 and a low of $12.50. The average price target has increased by 19.18% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 7:00 pm

UBER

A significant amount of unusual options activity has been detected for Uber Technologies (NYSE:UBER), with a majority of investors taking a bullish stance. The trades include 3 puts for a total of $248,476 and 12 calls for a total of $667,438. Whales have been targeting a price range from $22.5 to $50.0 for Uber over the last 3 months. The current price of UBER is up 1.69% at $44.45. Several research firms have maintained their ratings on Uber, with price targets ranging from $56 to $64.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 6:46 pm

MRK

A whale investor has taken a bullish stance on Merck & Co (NYSE:MRK), with 58% of investors opening trades with bullish expectations and 41% with bearish. The whale has been targeting a price range from $85.0 to $125.0 for Merck & Co over the last 3 months. The price of MRK is up 1.35% at $108.89. Truist Securities and Morgan Stanley have maintained their Buy and Equal-Weight ratings on Merck & Co, respectively, with price targets of $122 and $116.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 6:01 pm

HLT

In the last quarter, Hilton Worldwide Holdings (NYSE:HLT) received 4 somewhat bullish and 2 indifferent analyst ratings. The company has an average 12-month price target of $164.67, with a high of $170.00 and a low of $161.00. The average price target has increased by 3.13% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 6:00 pm

RMD

In the last quarter, ResMed (NYSE:RMD) received 2 bullish and 4 somewhat bullish ratings from analysts. No bearish or indifferent ratings were given. The company's average 12-month price target is $273.5, with a high of $290.00 and a low of $250.00. This average price target has increased by 0.74% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 6:00 pm